1 completed, 1 terminated, 1 unknown. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Eptifibatide: new trials by email Literature Review of Eptifibatide trials Research Report on Eptifibatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic Thrombolytic Agent - Acute Ischemic Stroke | Phase 1 / Phase 2 | Unknown | Baylor College of Medicine | 30 | 2022-02-18 | 2022-06-10 |
| A Safety Study of Eptifibatide in Patients With Sickle Cell Disease Eptifibatide, Placebo - Sickle Cell Disease | Phase 1 / Phase 2 | Terminated | University of North Carolina, Chapel Hill | 13 | 2009-01-01 | 2013-06-27 |
| Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial activase, integrilin - Stroke | Phase 1 / Phase 2 | Completed | University of Cincinnati | 94 | 2003-07-01 | 2009-05-08 |
Anemia, Sickle Cell (1) · Ischemic Stroke (1) · Stroke (1)
Baylor College of Medicine (1) · University of Cincinnati (1) · University of North Carolina, Chapel Hill (1)
United States (3)
Arthur Pancioli, MD (1) · Kenneth I Ataga, MD (1)